News

Are you planning to attend Medlab Middle East 2023? If so, make an appointment to stop by Mayo Clinic Laboratories’ booth Z3.A30 to learn more about our comprehensive menu of advanced diagnostic testing.

Topic highlights include: FDA considers major shift in COVID vaccine strategy, DNA from blood samples could help early cancer detection, Wisconsin researchers say, CDC informs staff of reorganization after pandemic criticisms

The New England Journal of Medicine recently published new findings on periprosthetic joint infection by Dr. Robin Patel.

Topic highlights include: Phoenix Children’s opens specialty clinic at Avondale campus, Moderna says RSV vaccine is effective in older adults, WHO questions severity of XBB.1.5 COVID subvariant as U.S. cases rise

Education on this topic decreases misdiagnosis and the possibility of misinterpreting the comments provided by the reporting laboratories.

Topic highlights include: With attention to mpox fading, health officials fear infections will go undetected and unreported, As COVID surges in China, US begins testing more travelers, FDA approves Alzheimer's drug that appears to modestly slow disease

Mayo Clinic Laboratories is excited to announce our participation in Medlab Middle East 2023, a medical conference and exhibition taking place in Dubai, United Arab Emirates, Feb. 6–9, 2023.

Mayo Clinic Laboratories, a leading reference laboratory, and Helix, the nation’s leading population genomics and viral surveillance company, today announced a new strategic collaboration that will provide life sciences customers access to a comprehensive joint laboratory offering for research and development initiatives across the drug development lifecycle. 

Mayo Clinic Laboratories, a leader in gastroenterology and patient care, will be exhibiting at the Crohn's & Colitis Congress, a premier conference for health care professionals and researchers interested in inflammatory bowel disease (IBD). Mayo Clinic Laboratories offers a comprehensive IBD test menu, including evaluations to diagnose, differentiate, and manage therapies to treat the condition.

Topic highlights include: Public health agencies try to restore trust as they fight misinformation, Telehealth brings expert sexual assault exams to rural patients, FDA decision on experimental Alzheimer’s drug expected this week.

In December 2022, Mayo Clinic Laboratories announced seventy-eight new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

Due to logistic challenges, we are experiencing shipment delays which may result in testing delays or cancelations.

Topic highlights include: Biden administration releases doses of flu medicine from national stockpile and pediatric medicine makers say they are running 24/7 to meet increased demand